Abstract:Researchers and decision‐makers often use evidence from randomised controlled trials (RCTs) to determine the efficacy or effectiveness of a treatment or intervention. Studies with observational designs are often used to measure the effectiveness of an intervention in 'real world' scenarios. Numerous study designs and their modifications (including both randomised and observational designs) are used for comparative effectiveness research in an attempt to give an unbiased estimate of whether one treatment is more effective or safer than another for a particular population. An up‐to‐date systematic analysis is needed to identify differences in effect estimates from RCTs and observational studies. This updated review summarises the results of methodological reviews that compared the effect estimates of observational studies with RCTs from evidence syntheses that addressed the same health research question. To assess and compare synthesised effect estimates by study type, contrasting RCTs with observational studies. To explore factors that might explain differences in synthesised effect estimates from RCTs versus observational studies (e.g. heterogeneity, type of observational study design, type of intervention, and use of propensity score adjustment). To identify gaps in the existing research comparing effect estimates across different study types. We searched MEDLINE, the Cochrane Database of Systematic Reviews, Web of Science databases, and Epistemonikos to May 2022. We checked references, conducted citation searches, and contacted review authors to identify additional reviews. We included systematic methodological reviews that compared quantitative effect estimates measuring the efficacy or effectiveness of interventions tested in RCTs versus in observational studies. The included reviews compared RCTs to observational studies (including retrospective and prospective cohort, case‐control and cross‐sectional designs). Reviews were not eligible if they compared RCTs with studies that had used some form of concurrent allocation. Using results from observational studies as the reference group, we examined the relative summary effect estimates (risk ratios (RRs), odds ratios (ORs), hazard ratios (HRs), mean differences (MDs), and standardised mean differences (SMDs)) to evaluate whether there was a relatively larger or smaller effect in the ratio of odds ratios (ROR) or ratio of risk ratios (RRR), ratio of hazard ratios (RHR), and difference in (standardised) mean differences (D(S)MD). If an included review did not provide an estimate comparing results from RCTs with observational studies, we generated one by pooling the estimates for observational studies and RCTs, respectively. Across all reviews, we synthesised these ratios to produce a pooled ratio of ratios comparing effect estimates from RCTs with those from observational studies. In overviews of reviews, we estimated the ROR or RRR for each overview using observational studies as the reference category. We appraised the risk of bias in the included reviews (using nine criteria in total). To receive an overall low risk of bias rating, an included review needed: explicit criteria for study selection, a complete sample of studies, and to have controlled for study methodological differences and study heterogeneity. We assessed reviews/overviews not meeting these four criteria as having an overall high risk of bias. We assessed the certainty of the evidence, consisting of multiple evidence syntheses, with the GRADE approach. We included 39 systematic reviews and eight overviews of reviews, for a total of 47. Thirty‐four of these contributed data to our primary analysis. Based on the available data, we found that the reviews/overviews included 2869 RCTs involving 3,882,115 participants, and 3924 observational studies with 19,499,970 participants. We rated 11 reviews/overviews as having an overall low risk of bias, and 36 as having an unclear or high risk of bias. Our main concerns with the included reviews/overviews were that some did not assess the quality of their included studies, and some failed to account appropriately for differences between study designs – for example, they conducted aggregate analyses of all observational studies rather than separate analyses of cohort and case‐control studies. When pooling RORs and RRRs, the ratio of ratios indicated no difference or a very small difference between the effect estimates from RCTs versus from observational studies (ratio of ratios 1.08, 95% confidence interval (CI) 1.01 to 1.15). We rated the certainty of the evidence as low. Twenty‐three of 34 reviews reported effect estimates of RCTs and observational studies that were on average in agreement. In a number of subgroup analyses, small differences in the effect estimates were detected: ‐ pharmaceutical interventions only (ratio of ratios 1.12, 95% CI 1.04 to 1.21); ‐ RCTs and observational -Abstract Truncated-

Meta-analyses involving cross-over trials: methodological issues

Meta-analysis of randomised trials with a continuous outcome according to baseline imbalance and availability of individual participant data

Meta-analysis of community-based cluster randomization trials with binary outcomes

Meta-Analytical Approaches to Ordinal Outcome Data in Clinical Interventional Studies: A Scoping Review with Reproducible Research

Handling Trial Participants with Missing Outcome Data when Conducting a Meta-Analysis: a Systematic Survey of Proposed Approaches.

Meta‐Analysis of Studies with Missing Data

Analyses of repeatedly measured continuous outcomes in randomized controlled trials needed substantial improvements

Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis

A scientific review on advances in statistical methods for crossover design

Data analysis of MS-based clinical lipidomics studies with crossover design: A tutorial mini-review of statistical methods

Data Extraction Error in Pharmaceutical Versus Non-Pharmaceutical Interventions for Evidence Synthesis: Study Protocol for a Crossover Trial

Estimating Individualized Treatment Regimes from Crossover Designs

Treatment Effects in RCTs and Nonrandomized Studies of Pharmacological Interventions

Behavioral carry-over effect and power consideration in crossover trials

Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study

Treatment Effects in Randomized and Nonrandomized Studies of Pharmacological Interventions: A Meta-Analysis

A meta-epidemiological analysis of post-hoc comparisons and primary endpoint interpretability among randomized noncomparative trials in clinical medicine

Sample Size Calculations for Randomized Controlled Trials with Repeatedly Measured Continuous Variables As Primary Outcomes Need Improvements: a Cross-Sectional Study.

Meta‐analysis of Randomized Trials for Health Care Interventions: One for All?

Testing Treatment-by-period Interaction in Four-Period Crossover Trials.

Statistical analysis of two arm randomized pre-post design with one post-treatment measurement